Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells.

Emerging therapies for chronic kidney disease: what is their role?

Patients' experiences and perspectives of living with CKD.

CCL2 DNA vaccine to treat renal disease.

DNA-small molecule chimera with responsive protein-binding ability.

Patients' priorities for health research: focus group study of patients with chronic kidney disease.

Regulatory immune cells in kidney disease.

By homing to the kidney, activated macrophages potently exacerbate renal injury.

Regulatory T cells in renal disease.

T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.